May 14, 2020 / 10:10 PM / 19 days ago

BRIEF-ChemoCentryx Says Entered Product Agreement With Patheon

May 14 (Reuters) - ChemoCentryx Inc:

* CHEMOCENTRYX SAYS ON MAY 8 CO ENTERED INTO PRODUCT AGREEMENT WITH PATHEON WHICH WAS MADE AS PER A MASTER MANUFACTURING SERVICES AGREEMENT DATED MARCH 18

* CHEMOCENTRYX INC - UNDER MASTER AGREEMENT AND PRODUCT AGREEMENT, PATHEON HAS AGREED TO MANUFACTURE AND SUPPLY AVACOPAN DRUG PRODUCT

* CHEMOCENTRYX INC - PRODUCT AGREEMENT HAS AN INITIAL TERM THAT EXPIRES ON DECEMBER 31, 2026

* CHEMOCENTRYX INC - MASTER AGREEMENT HAS AN INITIAL TERM THAT EXPIRES ON MARCH 18, 2023 Source text: (bit.ly/3bsKky0) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below